Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study.
Patients with genetically-based hyperlipidemias exhibit a wide phenotypic variability. Investigation of clinical and biochemical features is important for identifying genetically-based hyperlipidemias, determining disease prognosis, and initiating timely treatment. We analyzed genetic data from 3374...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0315693 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841555435137531904 |
|---|---|
| author | Anastasia V Blokhina Alexandra I Ershova Anna V Kiseleva Evgeniia A Sotnikova Anastasia A Zharikova Marija Zaicenoka Yuri V Vyatkin Vasily E Ramensky Vladimir A Kutsenko Olga A Litinskaya Maria S Pokrovskaya Svetlana A Shalnova Alexey N Meshkov Oxana M Drapkina |
| author_facet | Anastasia V Blokhina Alexandra I Ershova Anna V Kiseleva Evgeniia A Sotnikova Anastasia A Zharikova Marija Zaicenoka Yuri V Vyatkin Vasily E Ramensky Vladimir A Kutsenko Olga A Litinskaya Maria S Pokrovskaya Svetlana A Shalnova Alexey N Meshkov Oxana M Drapkina |
| author_sort | Anastasia V Blokhina |
| collection | DOAJ |
| description | Patients with genetically-based hyperlipidemias exhibit a wide phenotypic variability. Investigation of clinical and biochemical features is important for identifying genetically-based hyperlipidemias, determining disease prognosis, and initiating timely treatment. We analyzed genetic data from 3374 samples and compared clinical data, lipid levels (low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, triglycerides, and lipoprotein (a)), frequency, age at onset of coronary heart disease (CHD), and the severity of carotid and femoral atherosclerosis (plaque number, maximum stenosis, total stenosis, maximum plaque height, and plaque score) among patients with familial hypercholesterolemia (FH), familial dysbetalipoproteinemia (FD), polygenic hypercholesterolemia (HCL), severe HCL, and those without lipid disorders (n = 324). FH patients exhibited the highest LDL-C (median 8.03 mmol/L, p < 0.001). FD patients had elevated triglyceride levels (median 4.10 mmol/L), lower LDL-C (median 3.57 mmol/L), and high-density lipoprotein cholesterol (median 1.03 mmol/L) compared to FH, polygenic HCL, and severe HCL, p < 0.05. FH and FD patients had similar early onset of CHD, with a median age of 44 and 40 years and comparable frequencies of 29.5% and 31.0%, respectively. They were more likely to develop CHD than subjects without lipid disorders (p = 0.042 and p < 0.001, respectively). Additionally, FH patients had higher a carotid plaque number, total carotid stenosis, and carotid plaque score. This study presents the first simultaneous comparison of clinical and biochemical features among FD, FH, polygenic, and severe HCL, along with the first comprehensive evaluation of carotid and femoral atherosclerosis ultrasound parameters in FD patients. The results highlight distinct phenotypic features unique to each hyperlipidemia analyzed and underscore FH and FD as the most atherogenic hyperlipidemias. |
| format | Article |
| id | doaj-art-122b148e184648e38399f595812b6bc4 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-122b148e184648e38399f595812b6bc42025-01-08T05:32:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031569310.1371/journal.pone.0315693Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study.Anastasia V BlokhinaAlexandra I ErshovaAnna V KiselevaEvgeniia A SotnikovaAnastasia A ZharikovaMarija ZaicenokaYuri V VyatkinVasily E RamenskyVladimir A KutsenkoOlga A LitinskayaMaria S PokrovskayaSvetlana A ShalnovaAlexey N MeshkovOxana M DrapkinaPatients with genetically-based hyperlipidemias exhibit a wide phenotypic variability. Investigation of clinical and biochemical features is important for identifying genetically-based hyperlipidemias, determining disease prognosis, and initiating timely treatment. We analyzed genetic data from 3374 samples and compared clinical data, lipid levels (low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, triglycerides, and lipoprotein (a)), frequency, age at onset of coronary heart disease (CHD), and the severity of carotid and femoral atherosclerosis (plaque number, maximum stenosis, total stenosis, maximum plaque height, and plaque score) among patients with familial hypercholesterolemia (FH), familial dysbetalipoproteinemia (FD), polygenic hypercholesterolemia (HCL), severe HCL, and those without lipid disorders (n = 324). FH patients exhibited the highest LDL-C (median 8.03 mmol/L, p < 0.001). FD patients had elevated triglyceride levels (median 4.10 mmol/L), lower LDL-C (median 3.57 mmol/L), and high-density lipoprotein cholesterol (median 1.03 mmol/L) compared to FH, polygenic HCL, and severe HCL, p < 0.05. FH and FD patients had similar early onset of CHD, with a median age of 44 and 40 years and comparable frequencies of 29.5% and 31.0%, respectively. They were more likely to develop CHD than subjects without lipid disorders (p = 0.042 and p < 0.001, respectively). Additionally, FH patients had higher a carotid plaque number, total carotid stenosis, and carotid plaque score. This study presents the first simultaneous comparison of clinical and biochemical features among FD, FH, polygenic, and severe HCL, along with the first comprehensive evaluation of carotid and femoral atherosclerosis ultrasound parameters in FD patients. The results highlight distinct phenotypic features unique to each hyperlipidemia analyzed and underscore FH and FD as the most atherogenic hyperlipidemias.https://doi.org/10.1371/journal.pone.0315693 |
| spellingShingle | Anastasia V Blokhina Alexandra I Ershova Anna V Kiseleva Evgeniia A Sotnikova Anastasia A Zharikova Marija Zaicenoka Yuri V Vyatkin Vasily E Ramensky Vladimir A Kutsenko Olga A Litinskaya Maria S Pokrovskaya Svetlana A Shalnova Alexey N Meshkov Oxana M Drapkina Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study. PLoS ONE |
| title | Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study. |
| title_full | Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study. |
| title_fullStr | Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study. |
| title_full_unstemmed | Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study. |
| title_short | Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study. |
| title_sort | clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis a comprehensive comparative study |
| url | https://doi.org/10.1371/journal.pone.0315693 |
| work_keys_str_mv | AT anastasiavblokhina clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT alexandraiershova clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT annavkiseleva clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT evgeniiaasotnikova clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT anastasiaazharikova clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT marijazaicenoka clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT yurivvyatkin clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT vasilyeramensky clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT vladimirakutsenko clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT olgaalitinskaya clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT mariaspokrovskaya clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT svetlanaashalnova clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT alexeynmeshkov clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy AT oxanamdrapkina clinicalandbiochemicalfeaturesofatherogenichyperlipidemiaswithdifferentgeneticbasisacomprehensivecomparativestudy |